Document Classification

Section Type: RESULTS

Text: After 12 weeks of ROS treatment, there were significant increases in total cholesterol (TC) (4. 25 + / - 0. 22 vs 4. 80 + / - 0. 17 mmol/l, P < 0. 001), high-density lipoprotein cholesterol (HDL-C) (1. 25 + / - 0. 07 vs 1. 43 + / - 0. 06 mmol/l, P < 0. 05), and low-density lipoprotein cholesterol (LDL-C) (2. 70 + / - 0. 15 vs 3. 37 + / - 0. 17 mmol/l, P < 0. 05) without changes in triglyceride concentration, TC/HDL-C and LDL-C/HDL-C ratio.